Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
-- Research Veteran Brings More than 30 Years of Industry and NIH Experience to Kite Leadership Team --
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite, a Gilead Company (Nasdaq: GILD), today announced that Francesco Marincola, MD, will join the company as Senior Vice President and Global Head of Cell Therapy Research, effective February 1. Dr. Marincola will lead Kite’s Research organization across hematological malignancies and solid tumors.
“Franco’s proven track record in on...